Prognostic significance of preoperative DNA flow cytometry in surgically-treated cervical cancer

European Journal of Gynaecological Oncology

Volumn 24, Issue 1, 2003, Pages 13-17

  Reich, O ^a   Purstner P ^a   Klaritsch, P ^a   Haas, J ^a   Lahousen, M ^a   Tamussino, K ^a   Winter, R ^a  

^a UNIVERSITY OF GRAZ   (Austria)

Author keywords

Aneuploidy; Cervical cancer; DNA flow cytometry; Prognosis; Staging

Indexed keywords

ABDOMINAL HYSTERECTOMY; ADULT; AGED; ANEUPLOIDY; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CELL CYCLE S PHASE; FEMALE; FLOW CYTOMETRY; GENETIC HETEROGENEITY; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; METASTASIS; PELVIS LYMPHADENECTOMY; PLOIDY; PREOPERATIVE PERIOD; PROGNOSIS; UTERINE CERVIX BIOPSY; UTERINE CERVIX CANCER;

ADULT; AGED; ANALYSIS OF VARIANCE; BIOPSY, NEEDLE; CARCINOMA; CHI-SQUARE DISTRIBUTION; COHORT STUDIES; DISEASE-FREE SURVIVAL; DNA, NEOPLASM; FEMALE; FLOW CYTOMETRY; HUMANS; HYSTERECTOMY; MIDDLE AGED; NEOPLASM STAGING; PREOPERATIVE CARE; PROBABILITY; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

EID: 0037289288     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. M. Anton, R. Menutil, A. Rejthar, J. Kopecny, B. Ptackova, J. Zaloudik: "DNA flow cytometry: a predictor of a high-risk group in cervical cancer". Cancer Detect. Prev., 1997, 21, 242.
2. N. B. Atkin, B. M. Richards, A. Ross: "The deoxyribonucleic acid content of carcinoma of the uterus: an assessment of its possible significance in relation to histopathology and clinical course, based on data from 165 cases". Br. J. Cancer, 1959, 13, 773.
3. N. B. Atkin: "Prognostic significance of ploidy level in human tumors: I. Carcinoma of the uterus". J. Natl. Cancer Inst., 1956, 56, 909.
4. A. Böcking, C. P. Adler, H. H. Common, M. Hilgarth, B. Granzen, W. Auffermann: "Algorithm for a DNA-cytometric diagnosis and grading of malignancy". Anal. Quantitativ. Cytol., 1984, 6, 1.
5. A. Böcking: "DNA Cytometry". In: "Surgical Gynecologic Oncology", E. Burghardt, M. J. Webb, J. M. Monaghan, G. Kindermann (eds.), Stuttgart, Thieme, 1993, 250.
6. A. Böcking: "DNA measurments. When and why?". In: "Compendium on quality assurance, proficiency testing and workload limitations". In: "Tutorials of Cytology", G. L. Wied, C. M. Keebler, D. L. Rosenthal, U. Schenk, T. M. Somrak, G. P. Vooijs (eds.), Chicago, IL., Accademic press, 1995, 170.
7. A. C. Broders: "Squamous cell epithelioma of the lip: a study of five hundred and thirty-seven cases". J.A.M.A., 1920, 74, 656.
8. H. A. Casanova, M. Ohta, T. Kano, Y. Nishida, K. Sakakibara, T. Ishihara, Y. Tomoda: "Prognostic significance of nuclear analysis in invasive carcinoma of cervix patients treated by primary radiation". Acta Obst. Gynaec. Jpn., 1986, 38, 243.
9. J. P. Connor, D. S. Miller, K. D. Bauer, T. M. Murad, A. W. Rademaler, I. R. Lurain: "Flow-cytometric evaluation of early invasive cervical cancer". Obstet. Gynecol., 1993, 81, 367.
10. J. R. Davis, S. Aristizabal, D. L. Way, S. A. Weiner, M. J. Hicks: "DNA ploidy, grade, and stage in prognosis of uterine cervical cancer". Gynecol. Oncol., 1989, 32, 4.
11. J. E. D. Dyson, C. A. F. Joslin, R. I. Rothwell, P. Quirke, G. G. Khourg, C. C. Bird: "Flow cytofluometric evidence for the differential radioresponsiveness of aneuploid and diploid cervix tumours". Radiother. Oncol., 1987, 8, 263.
12. A. Fyles, P. Kirkbride: "Cervix uteri carcinoma". In: "Prognostic factors in cancer", P. Hermanek, M. K. Gospodarowicz, D. E. Henson, R. V. P. Hutter, L. H. Sob (eds.), Berlin, Springer, 1995, 185.
13. W. Goede, J. Schumann, J. Zaute: "The use of DAPI in pulse cytophotometry". In: "Pulse Cytophotometry", D. Lutz (ed.), European Press, Gent, 1978, 229.
14. A. Göppinger, N. Freudenberg, A. Ross, G. H. Hillemans, M. Hilgarth: "The prognostic significance of DNA distribution in squamous cell carcinomas of the uterine cervix". Anal. Quant. Cytol. Histol., 1986, 8, 148.
15. H. J. Grote, N. Friedrichs, N. Pomjanski, H. F. Guhde, O. Reich, A. Böcking: "Prognostic significance of DNA cytometry in carcinoma of the uterine cervix FIGO stage IB and II". Anal. Quant. Cytol. Histol., 2001, 23, 97.
16. D. Ireland, J. M. Monaghan: "A critical evaluation of three methods of studing cell proliferation in human cervical epithelium". Obstet. Gynecol., 1985, 65, 227.
17. A. Jakobsen, P. Bichel, M. Vaeth: "New prognostic factors in squamous cell carcinoma of the cervix uteri". Am. J. Clin. Oncol., 1985, 8, 39.
18. A. Jakobsen, P. Bichel, G. B. Kristinsen, M. Nylands: "Prognostic influence of ploidy level and histopathologic differentiation in cervical carcinoma stage Ib". Eur. J. Cancer Clin. Oncol., 1988, 24, 969.
19. G. G. Kenter, C. J. Cornelisse, E. J. Aartsen, W. Mooy, J. Hermans, A. P. M. Heintz, J. G. Fleuren: "DNA ploidy level as a prognostic factor in low stage carcinoma of the uterine cervix". Gynecol. Oncol., 1990, 39, 181.
20. G. Kovacs: "Molecular differential pathology for renal tumours". Histopathology, 1993, 22, 1.
21. G. B. Kristinsen, J. Kaern, V. M. Abeler, B. Hagmar, C. G. Tropé, E. O. Pettersen: "No prognsotic impact of flow-cytometric measured DNA ploidy and S-phase fraction in cancer of the uterine cervix: a prospective study of 465 patients". Gynecol. Oncol., 1995, 57, 79.
22. C. H. Lai, S. Hsueh, M. Y. Huang, M. F. Chang, Y. K. Soong: "The use and limitations of DNA flow cytometry in stage IB or II cervical carcinoma", Cancer, 1993, 72, 3655.
23. C. H. Lai, J. H. Hong, S. Hsueh, K. W. Ng, T. C. Chang, C. J. Tseng et al.: "Preoperative prognostic variables and the impact of postoperative adjuvant therapy on the outcomes of stage IB or II cervical carcinomas patients with or without pelvic lymph node metastases: an analysis of 891 cases". Cancer, 1999, 85, 1537.
24. A. Leminen, J. Paavonen, E. Vesterinen, M. Forss, T. Wahlström, P. Kulomad, M. Lehtinen: "Deoxyribonucleic acid flow cytometric analysis of cervical adenocarcinoma: Prognostic significance of deoxyribonucleic acid ploidy and S-phase fraction". Am. J. Obstet. Gynecol., 1990, 162, 848.
25. L. C. Lutgens, B. Schutte, J. M. De Jong, F. B. Thunissen: "DNA content as prognostic factor in cervical carcinoma stage Ib-III treated with radiotherapy". Gynecol. Oncol., 1994, 54, 275.
26. P. M. Magtibay, J. F. Perrone, R. Stanhope, J. A. Katzmann, G. L. Keeney, H. Li: "Flow-cytometric DNA analysis of early stage adenocarcinoma of the cervix". Gynecol. Oncol., 1999, 75, 20.
27. T. Matsuyama, I. Inoue, N. Tsukamoto, M. Kashimura, T. Kamura, T. Saito, H. Uchino: "Stage IB, IIa and IIb cervical cancer, post-surgical staging, and prognosis". Cancer, 1984, 54, 3072.
28. H. N. Nguyen, B. U. Sevin, H. E. Averette, H. E. Ganjei, P. Danjei, J. Perras, R. Ramos, R. Angioli, D. Donato, M. Penalver: "The role of DNA index as a prognostic factor in early cervical carcinoma", Gynecol. Oncol., 1993, 50, 53.
29. A. Onnis, T. Maggino, M. Marchetti: "Surgery as diagnostic and therapeutic moment in the management of cervical cancer". Eur. J. Gynecol. Oncol., 1985, 6, 20.
30. D. H. Rutgers, P. M. van der Linden, H.A. van Peperzeel: "DNA flow cytometry of squamous cell carcinomas of the uterine cervix. The identification of prognostically different subgroups". Radiother. Oncol., 1986, 7, 249.
31. R. E. Scully, T. A. Bonfiglio, R. J. Kurman, S. G. Silverberg, E. J. Wilkinson: "Histologic Typing of Female Genital Tract Tumors". Berlin, Springer, 1994.
32. P. Strang, U. Stendahl, R. Bergstrom, B. Frankendal, B. Tribukait: "Prognostic flow cytometric information in cervical squamous cell carcinoma: a multivariate analysis of 307 patients". Gynecol. Oncol., 1991, 43, 3.
33. R. Willen, C. Trope, E. Langstrom, J. Ranstam, D. Killandr, L. Clase: "Prospective malignancy grading and flow cytometry DNA distribution in biopsy speciemens from invasive squamous cell carcinoma of the uterine cervix". Anticancer Res., 1987, 7, 235.
34. R. Willen, A. Himmelmann, E. Langström, M. Fernö, J. Ranstam, B. Baldetrop et al.: "Prospective malignancy grading, flow cytometry DNA-measurements and adjuvant chemotherapy for invasive squamous cell carcinoma of the uterine cervix". Anticancer Res., 1993, 13, 1187.
35. R. Winter: "Lymphadenectomy". In: "Surgical Gynecologic Oncology", E. Burghardt, M. J. Webb, J. M. Monaghan, G. Kindermann, (eds.), Stuttgart, Thieme, 1993, 182.
36. T. C. Wright, A. Ferenczy, R. Kurman: "Carcinoma and other tumors of the cervix". In: "Blaustein's Pathology of the Female Genital Tract", R. J. Kurman (ed.), New York, Springer, 2001, 325.
37. J. M. Yu, H. Zhang, S. Q. Wang, H. Q. Miao, L. H. Yang, Y. T. Chen, G. D. Tian: "DNA ploidy analysis of effectiveness of radiation therapy for cervical carcinoma". Cancer, 1991, 68, 76.
38. G. M. Zanetta, J. A. Katzmann, G. L. Keeney, W. K. Kinney, S. S. Cha, K. C. Podratz: "Flow-cytometric DNA analysis of stages IB and IIA cervical carcinoma". Gynecol. Oncol., 1992, 46, 13.